It is time to start the renaissance of aptamers
06 October, 2022 by Peter DavisMacugen was the first RNA biotherapeutic approved by the US FDA in 2004, but did you know this is a pegylated RNA-modified aptamer?
CRISPR used to mimic disease, advancing cancer research
04 October, 2022The technology can activate any gene — including those that have been silenced — allowing new drug targets and causes of drug resistance to be further explored.
DNA transfer to avoid mito inheritance appears safe
05 September, 2022Transferring the nuclear genome from one egg into the cytoplasm of a donor egg can enable women carrying mutations in their mitochondrial DNA to have healthy babies.
We inherit more epigenetic info than we thought
26 August, 2022Epigenetic information, which sits on top of DNA and is normally reset between generations, is more frequently carried from mother to offspring than previously thought.
Revealing the genetic architecture underlying substance abuse
22 August, 2022The genes underlying cigarette smoking are linked to the perception of pain and response to food, as well as the abuse of drugs such as cocaine.
Uni Melbourne and Colossal plan to bring back Tasmanian tiger
19 August, 2022A University of Melbourne research lab is partnering with genetic engineering company Colossal Biosciences to bring the thylacine back from extinction.
QIAGEN QIAseq UPXome RNA Library Kit
16 August, 2022QIAGEN's QIAseq UPXome RNA Library Kit, specifically designed for ultralow-input samples, supports labs interested in 3′ RNA sequencing as well as complete transcriptome RNA sequencing.
QIAGEN QIAseq Targeted DNA Pro Panels
12 August, 2022QIAGEN says its QIAseq Targeted DNA Pro Panels are based on a chemistry that halves to six hours the time researchers need for library preparation of DNA samples.
Warning: CRISPR therapeutics can damage the genome
12 August, 2022Investigating the impact of CRISPR technology on T cells, researchers detected a significant loss of genetic material in some treated cells.
Decades in the making: RNA's importance to Australia
10 August, 2022 by Peter DavisProfessor Pall (Palli) Thordarson, an award-winning researcher, is set to kickstart RNA capabilities in NSW and finally launch our genetic medicine ecosystem.
Victorian Govt invests in mRNA Innovation Hub
09 August, 2022The Victorian mRNA Innovation Hub will work to develop next-generation mRNA vaccines and therapeutics to treat a range of diseases.
Protein improves metabolism of insulin-dependent diabetics
01 August, 2022Scientists have identified a protein called S100A9 that regulates blood glucose, lipids and ketones, without the side effects of insulin.
Genetic link between Alzheimer's and gut disorders confirmed
21 July, 2022People with gut disorders may be at greater risk of developing Alzheimer's disease, according to a groundbreaking study.
Many human genomes shaped by 'founder events'
27 June, 2022The genomes of many human populations show evidence of so-called founder events, which occur when a small number of initial members start a new population and can lead to low genetic diversity.
Sperm epigenetic aging may help predict pregnancy success
10 June, 2022Sperm epigenetic aging — the biological, rather than chronological, aging of sperm — has the potential to predict the success and time it takes to become pregnant.
